NUVB
Nuvation Bio Inc.Data: 2026-09-11
Quick Stats
Sep 11, 202639.9
AI Score
SELL0.81
Volume Ratio
Nov 02, 2026
Next Earnings
12
+ve Days (30d)
16
-ve Days (30d)
NUVB Price vs Max Options Open Interest
How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.
NUVB Max Change In Options Open Interest
How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.
NUVB Options - Sort by Max open Interest (near term)
13th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NUVB Daily Out of Money Options - Sort by Max open Interest (near term)
13th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NUVB Daily In the Money Options - Sort by Max open Interest (near term)
13th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NUVB Most Active Options by Volume(near term)
13th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NUVB Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Volume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
NUVB Stock Summary
Last updated Sep 11, 2026
NUVB is currently trading at $6.07, positioned above its 200-day moving average of $5.95, indicating a long-term uptrend. The stock has a 52-week range of $2.99 to $9.75.
Technical Analysis: The 50-day moving average stands at $6.41, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 39.756, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.017, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates NUVB at 39.9/100 with a SELL recommendation.
NUVB (Nuvation Bio Inc.) Indicators
Last updated Sep 11, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 39.756 |
| CMF (20) | -0.017 |
| ROC (10) | -13.162 |
| ADX (14) | 14.452 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.002 |
| AROONOSC (14) | -71.429 |
| WILLAMS %R (14) | -90.244 |
| MFI (14) | 30.828 |
NUVB Candlestick Patterns
Validated patterns fired in the last 10 sessions. Hit rate = how often price moved in the signal's direction within 5 trading days (backtest: 2.7M signals, 3,500 liquid stocks, Feb 2025–Sep 2026). Baseline: a random stock closes higher 5 days later 53% of the time. Click a row to see the candle on the chart.
| Date | Pattern | Signal | 5-Day Hit Rate | Edge vs Baseline | Sample |
|---|---|---|---|---|---|
| Sep 09 | Inverted Hammer | Bullish | 56.4% | +3.4 pts | 19834 |
| Sep 01 | Inverted Hammer | Bullish | 56.4% | +3.4 pts | 19834 |
These are statistical tilts, not standalone trade setups. Only patterns with a measured edge are shown — roughly 50 of 60 textbook patterns showed no edge and are hidden.
Nuvation Bio Inc. is above the 200 Day SMA but below the 50 Day SMA — long-term uptrend intact but under near-term pressure (Mixed).
NUVB Moving Averages Analysis
Nuvation Bio Inc. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Sep 11, 2026
NUVB (Nuvation Bio Inc.) Simple Moving Averages
Moving Averages are last updated Sep 11, 2026
| Days | MA |
|---|---|
| 10 | 6.6 |
| 20 | 6.72 |
| 30 | 6.6 |
| 50 | 6.41 |
| 100 | 5.68 |
| 200 | 5.95 |
NUVB Fundamental Analysis
| P/E (Forward) | -- |
| P/E (Trailing) | -- |
| Market Cap ($) | 2.2 billion |
| Earnings/Share ($) | -0.42 |
| Net Profit Margin (%) | -0.8819 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.29 |
| EPS Estimate Next Year ($) | -0.015 |
| WallStreet Target Price ($) | 13.10 |
| Most Recent Quarter |
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.